BACKGROUND: A limitation of stress myocardial perfusion imaging (MPI) is the inability to detect non-obstructive coronary artery disease (CAD). One advantage of MPI with a hybrid CT device is the ability to obtain same-setting measurement of the coronary artery calcium score (CACS). METHODS AND RESULTS: Utilizing our single-center nuclear database, we identified 760 consecutive patients with: (1) no CAD history; (2) a normal clinically indicated Rb-82 PET/CT stress perfusion study; and (3) a same-setting CAC scan. 487 of 760 patients (64.1%) had subclinical CAD based on an abnormal CACS. Of those with CAC, the CACS was > or =100, > or =400, and > or =1000 in 47.0%, 22.4%, and 8.4% of patients, respectively. Less than half of the patients with CAC were receiving aspirin or statin medications prior to PET/CT imaging. Patients with CAC were more likely to be initiated or optimized on proven medical therapy for CAD immediately following PET/CT MPI compared to those without CAC. CONCLUSIONS: Subclinical CAD is common in patients without known CAD and normal myocardial perfusion assessed by hybrid PET/CT imaging. Identification of CAC influences subsequent physician prescribing patterns such that those with CAC are more likely to be treated with proven medical therapy for the treatment of CAD.
BACKGROUND: A limitation of stress myocardial perfusion imaging (MPI) is the inability to detect non-obstructive coronary artery disease (CAD). One advantage of MPI with a hybrid CT device is the ability to obtain same-setting measurement of the coronary artery calcium score (CACS). METHODS AND RESULTS: Utilizing our single-center nuclear database, we identified 760 consecutive patients with: (1) no CAD history; (2) a normal clinically indicated Rb-82 PET/CT stress perfusion study; and (3) a same-setting CAC scan. 487 of 760 patients (64.1%) had subclinical CAD based on an abnormal CACS. Of those with CAC, the CACS was > or =100, > or =400, and > or =1000 in 47.0%, 22.4%, and 8.4% of patients, respectively. Less than half of the patients with CAC were receiving aspirin or statin medications prior to PET/CT imaging. Patients with CAC were more likely to be initiated or optimized on proven medical therapy for CAD immediately following PET/CT MPI compared to those without CAC. CONCLUSIONS: Subclinical CAD is common in patients without known CAD and normal myocardial perfusion assessed by hybrid PET/CT imaging. Identification of CAC influences subsequent physician prescribing patterns such that those with CAC are more likely to be treated with proven medical therapy for the treatment of CAD.
Authors: R Haberl; A Becker; A Leber; A Knez; C Becker; C Lang; R Brüning; M Reiser; G Steinbeck Journal: J Am Coll Cardiol Date: 2001-02 Impact factor: 24.094
Authors: Wenchun Qu; Thuy T Le; Stanley P Azen; Min Xiang; Nathan D Wong; Terence M Doherty; Robert C Detrano Journal: Diabetes Care Date: 2003-03 Impact factor: 19.112
Authors: Lars Husmann; Mischa Wiegand; Ines Valenta; Oliver Gaemperli; Tiziano Schepis; Patrick T Siegrist; Mehdi Namdar; Christophe A Wyss; Hatem Alkadhi; Philipp A Kaufmann Journal: Int J Cardiovasc Imaging Date: 2007-12-25 Impact factor: 2.357
Authors: Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom Journal: J Nucl Cardiol Date: 2006 Jan-Feb Impact factor: 5.952
Authors: Raymond R Russell; Brian G Abbott; James A Arrighi; Frank M Bengel; James A Case; Tracy L Faber; Thomas A Holly; Jennifer H Mieres; Todd D Miller; Leslee J Shaw; Frans J Th Wackers; Jeroen J Bax Journal: J Nucl Cardiol Date: 2009-01-22 Impact factor: 5.952
Authors: Mohamed Mouden; Jan Paul Ottervanger; Jorik R Timmer; Stoffer Reiffers; Ad H J Oostdijk; Siert Knollema; Pieter L Jager Journal: J Nucl Cardiol Date: 2013-12-07 Impact factor: 5.952
Authors: Harshal R Patil; Nirav T Patil; Samantha I King; Evan O'Keefe; Rajiv Chhabra; Shaya Ansari; Kevin F Kennedy; Damini Dey; James H O'Keefe; John H Helzberg; Randall C Thompson Journal: J Nucl Cardiol Date: 2014-08-16 Impact factor: 5.952
Authors: Jochen A C van Osch; Mohamed Mouden; Jorn A van Dalen; Jorik R Timmer; Stoffer Reiffers; Siert Knollema; Marcel J W Greuter; Jan Paul Ottervanger; Piet L Jager Journal: Int J Cardiovasc Imaging Date: 2014-03-28 Impact factor: 2.357